Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups

J Infect Dis. 1983 Dec;148(6):1136-59. doi: 10.1093/infdis/148.6.1136.

Authors

J B Robbins, R Austrian, C J Lee, S C Rastogi, G Schiffman, J Henrichsen, P H Mäkelä, C V Broome, R R Facklam, R H Tiesjema, et al.

PMID: 6361173
DOI: 10.1093/infdis/148.6.1136

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Review

MeSH terms

ABO Blood-Group System / immunology
Adult
Animals
Antibodies, Bacterial / analysis
Bacterial Vaccines / administration & dosage
Bacterial Vaccines / immunology*
Child
Cross Reactions
Humans
Infant
Meningitis, Pneumococcal / microbiology
Opsonin Proteins
Phagocytosis
Pneumococcal Infections / microbiology
Pneumococcal Infections / prevention & control*
Pneumococcal Vaccines
Polysaccharides, Bacterial / classification
Polysaccharides, Bacterial / immunology
Species Specificity
Streptococcus pneumoniae / classification
Streptococcus pneumoniae / immunology*
Vaccination

Substances

ABO Blood-Group System
Antibodies, Bacterial
Bacterial Vaccines
Opsonin Proteins
Pneumococcal Vaccines
Polysaccharides, Bacterial